REGEN BIOPHARMA PFD A (RGBPP) Revenue by Year
REGEN BIOPHARMA PFD A generated $237K in revenue in fiscal year 2025. That is unchanged from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $237K in revenue. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters REGEN BIOPHARMA PFD A has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RGBPP Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
RGBPP Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More REGEN BIOPHARMA PFD A financials
Frequently Asked Questions
What was REGEN BIOPHARMA PFD A's revenue in fiscal year 2025?
REGEN BIOPHARMA PFD A generated $237K in revenue in fiscal year 2025.
How fast is REGEN BIOPHARMA PFD A's revenue growing?
REGEN BIOPHARMA PFD A (RGBPP) revenue was essentially unchanged year over year, at $237K in fiscal year 2025 against $237K the year before.
What is REGEN BIOPHARMA PFD A's revenue over the last twelve months?
REGEN BIOPHARMA PFD A (RGBPP) reported $237K in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
What was REGEN BIOPHARMA PFD A's revenue in the most recent quarter?
REGEN BIOPHARMA PFD A (RGBPP) reported $59K in revenue in Q3 2026. That is unchanged from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what REGEN BIOPHARMA PFD A (RGBPP) reported on that line in every period on record.